| Aspect | Summary for AZI2/NAP1 | Key evidence / mechanistic detail | Citations |
|---|---|---|---|
| Verified identity | Human **AZI2** encodes **5-azacytidine-induced protein 2**, also called **NAK-associated protein 1 (NAP1)**, a TBK1 adaptor protein. | Recent literature explicitly equates AZI2 with NAP1 and studies it in human cell systems in innate immunity, autophagy, mitosis, and TNF signaling. | (pqac-00000002, pqac-00000003, pqac-00000004) |
| Primary molecular function | **Scaffold/adaptor for TBK1** rather than an enzyme or transporter. | AZI2 binds TBK1 and promotes its activation by adaptor-driven assembly/oligomerization and TBK1 Ser172 autophosphorylation; it links TBK1 to different signaling platforms and cargo receptor complexes. | (pqac-00000002, pqac-00000007, pqac-00000017) |
| TBK1-binding role | AZI2 directly engages the **TBK1 adaptor-binding region** through its own **TBK1-binding domain (TBD)**. | Reviews and mechanistic studies describe a central TBD in NAP1/AZI2 that associates with the C-terminal adaptor-binding domain of TBK1; adaptor competition with TANK/SINTBAD helps specify pathway usage. | (pqac-00000001, pqac-00000017) |
| Structural features / domains | Modular coiled-coil adaptor with **homodimerization region**, **central TBD**, intrinsically disordered regions, and a **FIP200-binding region (FIR)** used in selective autophagy. | NAP1/AZI2 is described as one of three homologous TBK1 adaptors; structural work resolved NAP1 FIR interaction with RB1CC1/FIP200 and places NAP1 in NDP52–TBK1–FIP200 assemblies. | (pqac-00000001, pqac-00000006) |
| Type I IFN pathway | AZI2 is a positive regulator of **TBK1–IRF3/IRF7** signaling for type I interferon induction. | TBK1 is the central kinase downstream of RLR-MAVS, cGAS-STING, and TLR3/TRIF; AZI2/NAP1 is one of the key TBK1 adaptors that helps activate this axis. In some contexts, AZI2 also promotes DDX3X–IRF3 signaling and pro-inflammatory chemokine transcription. | (pqac-00000003, pqac-00000007, pqac-00000013) |
| TNF signaling pathway | AZI2 helps recruit **TBK1 to the TNF receptor signaling complex** to restrain inflammatory cell death. | In 2024 work, AZI2 and TANK cooperatively sustained TBK1 activation in TNF signaling; AZI2 was recruited later via A20, enabling TBK1-dependent suppression of RIPK1-driven apoptosis/necroptosis and limiting excessive NF-κB pathway activation. | (pqac-00000004, pqac-00000014) |
| Selective autophagy pathway | AZI2 bridges **cargo receptors** to **TBK1** and promotes selective autophagy execution. | NDP52 binds NAP1/SINTBAD, which recruit TBK1; NAP1 also engages FIP200/RB1CC1, integrating TBK1 and ULK/FIP200 modules at cargo. Structural work shows competitive interactions among NAP1, RB1CC1, and ATG8-family proteins. | (pqac-00000006, pqac-00000010) |
| Mitophagy control | AZI2 acts as a **context-dependent rheostat** in mitophagy. | Under PINK1/Parkin mitophagy, NAP1/SINTBAD can inhibit OPTN-driven initiation by competing for TBK1, yet support NDP52-driven progression by recruiting TBK1 and stabilizing NDP52–FIP200 interactions. Artificial mitochondrial tethering of NAP1 was sufficient to induce mitophagy-like responses. | (pqac-00000000, pqac-00000010, pqac-00000015) |
| Mitosis and cytokinesis | AZI2 is required for **TBK1 activation during cell division** and supports accurate mitosis/cytokinesis. | NAP1/AZI2 localizes with TBK1 at centrosomes; loss of NAP1 reduces mitotic p-TBK1 and causes slower growth, binucleation/multinucleation, spindle defects, lagging chromosomes, and cytokinetic abnormalities. | (pqac-00000002, pqac-00000012) |
| Cell-death control | AZI2 contributes to a **cell-death checkpoint** by supporting TBK1 anti-death signaling. | In TNF signaling, AZI2 enables TBK1-mediated inhibition of RIPK1 activation; in AML-related work, NAP1 also interacted with PTPN23 to facilitate endosomal sorting of TNFR1 and influence sensitivity to TNFα-induced cytotoxicity. | (pqac-00000004, pqac-00000005, pqac-00000014) |
| Cancer-related implementation | AZI2-TBK1 signaling can be exploited to increase **tumor immunogenicity** and **CD8 T-cell infiltration**. | In breast cancer models, RB1CC1/FIP200 loss caused AZI2 puncta, TBK1 activation, DDX3X–IRF3 signaling, chemokine induction, and increased CD8+ T-cell infiltration; Lys05 was identified as a pharmacologic inducer of this pathway. | (pqac-00000003, pqac-00000008, pqac-00000013) |
| Basal subcellular localization | Predominantly **diffuse cytosolic** under unstimulated conditions. | Mitophagy and condensate studies report NAP1/SINTBAD dispersed through the cytosol before pathway induction. | (pqac-00000010) |
| Localization in mitosis | **Centrosomes** and associated spindle structures. | NAP1 is described as a centrosomal protein required for local TBK1 activation during mitosis; activated TBK1 signal extends across centrosome/spindle regions. | (pqac-00000002, pqac-00000016) |
| Localization in mitophagy | Recruited to **depolarized mitochondria** and early autophagosome initiation sites. | Upon oligomycin/antimycin treatment, HA-NAP1 accumulated on damaged mitochondria and colocalized with **WIPI2**, indicating function at phagophore initiation sites. | (pqac-00000010) |
| Localization in selective-autophagy blockade | Forms **cytoplasmic AZI2 puncta** with active TBK1, ubiquitin, and cargo receptors. | RB1CC1 depletion caused AZI2 puncta that colocalized with p-TBK1, SQSTM1/p62, TAX1BP1, NBR1, OPTN, and ubiquitin, supporting a role at unresolved cargo receptor complexes rather than generic bulk autophagy structures. | (pqac-00000003, pqac-00000013) |
| Localization in innate immune signaling | Present in **cytoplasmic liquid-like condensates** after danger signaling. | Endogenous NAP1, SINTBAD, TANK, and TBK1 accumulate in cytoplasmic condensates after viral infection or 5'ppp-dsRNA stimulation; NAP1 condensates concentrate TBK1 and later PP2A. | (pqac-00000001, pqac-00000011) |
| Regulation by condensate formation | AZI2 can first **activate** and then **limit** TBK1 signaling through condensate dynamics. | NAP1 initially enhances TBK1 activity; subsequent TBK1-dependent phosphorylation favors NAP1 condensate formation that concentrates TBK1 with PP2A phosphatase, promoting TBK1 dephosphorylation and dampening IFN output. | (pqac-00000001, pqac-00000011) |
| Regulation by competing adaptors / cargo receptors | AZI2 function is tuned by competition with **OPTN**, **NDP52**, **TANK**, and **SINTBAD** for TBK1 or pathway assembly. | In mitophagy, NAP1/SINTBAD compete with OPTN for TBK1 but support NDP52-driven progression; in innate signaling, the homologous adaptors compete for TBK1 binding and create pathway-specific assemblies. | (pqac-00000000, pqac-00000010, pqac-00000017) |
| Regulation by FIP200/RB1CC1 | RB1CC1/FIP200 restrains AZI2-TBK1 signaling in some settings but also physically interfaces with NAP1 in selective autophagy. | Structural and cancer studies show NAP1 binds FIP200/RB1CC1; loss of RB1CC1 causes AZI2 accumulation in puncta and TBK1 hyperactivation, indicating a regulatory brake on AZI2-TBK1 signaling. | (pqac-00000006, pqac-00000008, pqac-00000013) |
| Regulation by proteostasis | AZI2 abundance is controlled by **TBK1-dependent phosphorylation and ubiquitin-proteasome degradation** in mitosis. | Phosphoproteomic and cell-cycle studies identified NAP1 Ser318 as a TBK1-regulated site associated with mitotic degradation, supporting negative feedback on NAP1 levels during cell division. | (pqac-00000002, pqac-00000016) |


*Table: This table compiles the main experimentally supported functions of human AZI2/NAP1, emphasizing its role as a TBK1 adaptor across innate immune signaling, selective autophagy, TNF signaling, and mitosis. It also summarizes context-specific localization, structural features, and regulatory mechanisms with direct citations to the available evidence.*